Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 323

Related Citations for PubMed (Select 15317889)

1.

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.

N Engl J Med. 2004 Aug 19;351(8):760-8.

3.

Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.

Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli L, Gallarda J.

Transfusion. 2002 Nov;42(11):1507-13.

PMID:
12421226
4.

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.

Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group.

J Virol Methods. 2003 Sep;112(1-2):145-51.

PMID:
12951223
5.

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.

Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN.

Transfusion. 2002 Jun;42(6):792-7.

PMID:
12147034
6.
7.

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.

Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH.

N Engl J Med. 2005 Aug 4;353(5):460-7.

8.

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.

Zou S, Dodd RY, Stramer SL, Strong DM; Tissue Safety Study Group.

N Engl J Med. 2004 Aug 19;351(8):751-9.

9.

The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K; Japanese Red Cross NAT Screening Research Group.

Microbiol Immunol. 2001;45(9):667-72.

PMID:
11694079
10.

Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

Busch MP, Glynn SA, Wright DJ, Hirschkorn D, Laycock ME, McAuley J, Tu Y, Giachetti C, Gallarda J, Heitman J, Kleinman SH; National Heart, Lung, Blood Institute Nucleic Acid Test Study Group*.

Transfusion. 2005 Dec;45(12):1853-63.

PMID:
16371038
11.

Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.

Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, Hedges D, Seifried E.

Transfusion. 2002 Jul;42(7):862-8.

PMID:
12375658
12.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

Weusten JJ, van Drimmelen HA, Lelie PN.

Transfusion. 2002 May;42(5):537-48.

PMID:
12084161
13.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
14.

[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].

Pillonel J, Laperche S; Groupe "Agents Transmissibles par Transfusion" de la Société française de transfusion sanguine; Etablissement français du sang; Centre de transfusion sanguine des armées.

Transfus Clin Biol. 2004 Apr;11(2):81-6. French.

PMID:
15120104
15.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
17.
18.

Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.

Jarvis LM, Dow BC, Cleland A, Davidson F, Lycett C, Morris K, Webb B, Jordan A, Petrik J.

Vox Sang. 2005 Oct;89(3):128-34.

PMID:
16146504
19.

Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.

Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ.

Saudi Med J. 2006 Jun;27(6):781-7.

PMID:
16758035
20.

A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.

Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX.

Transfusion. 2007 Nov;47(11):2011-6.

PMID:
17958529
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk